Pfizer Inc and BioNTech SE said on Wednesday their Covid-19 vaccine was safe and effective and produced robust antibody responses in 12- to 15-year-olds, paving the way for them to seek US emergency use authorisation in weeks.
Pfizer hopes that vaccinations of the group could begin before the next school year, Albert Bourla, Pfizer's chairperson and chief executive, said in a statement...
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む: